GlassScriptPhysician profile
Paul S Lee
NPI 1356826374
$314.28
in general payments reported to CMS, 2019-2025
8 companies · $73.72 in 2025
The $73.72 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $100 · 2021: $12.37 · 2023: $30.00 · 2024: $98.17 · 2025: $73.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $201.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ivoclar Vivadent, INC. | $89.00 | 2020 | |
| Depuy Synthes Sales INC. | $49.87 | 2023-2024 | Trumatch, Na, Vivigen Mis Delivery System |
| Axogen | $44.90 | 2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector |
| Dentsply Sirona INC | $33.89 | 2025 | Midwest Stylus Plus |
| Stryker Corporation | $33.40 | 2024 | Na, Patient-Fitted Tmj Reconstructive Prosthesis System, Smartlock |
| Orapharma, A Division of Bausch Health US, LLC | $29.39 | 2021-2025 | Ossix Plus, Arestin |
| Voco America INC. | $22.81 | 2025 | Grandio So, Grandio So Heavy Flow, Meron Plus Qm |
| Biohorizons Implant Systems INC. | $11.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.